Vimarsana
Biggest News Aggregation in the World

Page 6 - Alvr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alvr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alvr Today - Breaking & Trending Today

AlloVir (NASDAQ:ALVR) Trading Up 22.4% - Vimarsana News

AlloVir (NASDAQ:ALVR) Trading Up 22.4%

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was up 22.4% during mid-day trading on Tuesday . The stock traded as high as $5.99 and last traded at $5.46. Approximately 449,994 shares traded hands during mid-day trading, an increase of 79% from the average daily volume of 250,811 shares. The stock had previously closed at $4.46. Wall […]

Blueprint Medicines (NASDAQ:BPMC) Stock Price Down 5.9% on Insider Selling - Vimarsana News

Blueprint Medicines (NASDAQ:BPMC) Stock Price Down 5.9% on Insider Selling

AlloVir, Inc. (NASDAQ:ALVR – Get Rating)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $5.82, but opened at $5.70. AlloVir shares last traded at $5.74, with a volume of 28,602 shares traded. Wall Street Analyst Weigh In Separately, SVB Securities upped their target price on shares […]

SVB Securities Boosts AlloVir (NASDAQ:ALVR) Price Target to $19.00 - Vimarsana News

SVB Securities Boosts AlloVir (NASDAQ:ALVR) Price Target to $19.00

AlloVir (NASDAQ:ALVR – Get Rating) had its price objective upped by SVB Securities from $16.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. ALVR has been the subject of a number of other reports. Morgan Stanley decreased their target price on AlloVir from $27.00 to $20.00 and set an overweight rating […]

Source: wkrb13.com
AlloVir (NASDAQ:ALVR) Price Target Raised to $19.00 at SVB Securities - Vimarsana News

AlloVir (NASDAQ:ALVR) Price Target Raised to $19.00 at SVB Securities

AlloVir (NASDAQ:ALVR – Get Rating) had its price objective boosted by research analysts at SVB Securities from $16.00 to $19.00 in a report issued on Wednesday, The Fly reports. SVB Securities’ target price would suggest a potential upside of 420.55% from the company’s current price. Other equities analysts have also recently issued reports about the […]

AlloVir, Inc. (NASDAQ:ALVR) Sees Significant Growth in Short Interest - Vimarsana News

AlloVir, Inc. (NASDAQ:ALVR) Sees Significant Growth in Short Interest

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,460,000 shares, an increase of 11.6% from the March 15th total of 5,790,000 shares. Based on an average daily trading volume, of 277,500 shares, the short-interest ratio is […]

Source: wkrb13.com